ATE305783T1 - Verwendung von diaminotrifluoromethylpyridinderivaten für die prevention und behandlung von lebererkrankungen - Google Patents

Verwendung von diaminotrifluoromethylpyridinderivaten für die prevention und behandlung von lebererkrankungen

Info

Publication number
ATE305783T1
ATE305783T1 AT01948938T AT01948938T ATE305783T1 AT E305783 T1 ATE305783 T1 AT E305783T1 AT 01948938 T AT01948938 T AT 01948938T AT 01948938 T AT01948938 T AT 01948938T AT E305783 T1 ATE305783 T1 AT E305783T1
Authority
AT
Austria
Prior art keywords
group
alkyl
prevention
treatment
liver disease
Prior art date
Application number
AT01948938T
Other languages
English (en)
Inventor
Shuichi Yotsuya
Kimie Sakai
Original Assignee
Ishihara Sangyo Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ishihara Sangyo Kaisha filed Critical Ishihara Sangyo Kaisha
Application granted granted Critical
Publication of ATE305783T1 publication Critical patent/ATE305783T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)
AT01948938T 2000-02-01 2001-01-30 Verwendung von diaminotrifluoromethylpyridinderivaten für die prevention und behandlung von lebererkrankungen ATE305783T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000024350 2000-02-01
PCT/JP2001/000615 WO2001056569A1 (fr) 2000-02-01 2001-01-30 Medicaments pour le traitement et la prevention d'affections hepatiques, a base de derives de diaminotrifluoromethylpyridine

Publications (1)

Publication Number Publication Date
ATE305783T1 true ATE305783T1 (de) 2005-10-15

Family

ID=18550354

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01948938T ATE305783T1 (de) 2000-02-01 2001-01-30 Verwendung von diaminotrifluoromethylpyridinderivaten für die prevention und behandlung von lebererkrankungen

Country Status (7)

Country Link
US (1) US6664279B2 (de)
EP (1) EP1252891B1 (de)
AT (1) ATE305783T1 (de)
AU (1) AU2001228862A1 (de)
DE (1) DE60113808T2 (de)
TW (1) TWI257864B (de)
WO (1) WO2001056569A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101246568B1 (ko) * 2006-06-09 2013-03-25 삼성전자주식회사 모바일 디스플레이 장치에서 가로 화면을 디스플레이하는방법과 장치 및 이를 포함하는 모바일 액정 표시 장치
JP5584518B2 (ja) 2009-05-28 2014-09-03 石原産業株式会社 ジアミノトリフルオロメチルピリジン誘導体を含有する抗ショック剤
TW201929851A (zh) 2017-11-02 2019-08-01 日商石原產業股份有限公司 緩釋性醫藥組成物
US20210038576A1 (en) 2018-03-01 2021-02-11 Ishihara Sangyo Kaisha, Ltd. Pharmaceutical Composition with Excellent Storage Stability
EP3970797A4 (de) 2019-05-15 2022-12-28 Ishihara Sangyo Kaisha, Ltd. Wasserfreie kristalle von mononatrium-n-(2-ethylsulfonylamino-5-trifluormethyl-3-pyridyl)cyclohexancarboxamid
JPWO2022071233A1 (de) 2020-09-29 2022-04-07

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2777678B2 (ja) 1990-06-11 1998-07-23 敏一 中村 組換ヒト肝実質細胞増殖因子及びその製造方法
ZA915023B (en) 1990-07-10 1992-05-27 Ishihara Sangyo Kaisha Diaminotrifluoromethylpyridine derivatives,process for their production and phospholipase a2 inhibitor containing them
DK0465913T3 (da) * 1990-07-10 1997-10-20 Ishihara Sangyo Kaisha Diaminotrifluormethylpyridinderivater, fremgangsmåder til fremstilling deraf og phospholipase-A2-inhibitor indeholdende samme
JPH06239856A (ja) 1993-02-15 1994-08-30 Shin Nippon Yakuhin Kk １，３−ベンゾオキサチオール−２−チオン誘導体
JP3186365B2 (ja) 1993-09-02 2001-07-11 日本油脂株式会社 肝疾患治療薬
JPH10298076A (ja) 1997-02-28 1998-11-10 Ishihara Sangyo Kaisha Ltd 抗癌剤
ZA981430B (en) 1997-02-28 1998-08-24 Ishihara Sangyo Kaisha Anticancer composition
JPH11228563A (ja) 1998-02-19 1999-08-24 Dainippon Pharmaceut Co Ltd ３−ヒドロキシ−２，３−ジヒドロベンゾフラン（又はベンゾチオフェン）誘導体及びそれを有効成分とする肝疾患治療薬

Also Published As

Publication number Publication date
AU2001228862A1 (en) 2001-08-14
DE60113808D1 (de) 2006-02-16
US20030018054A1 (en) 2003-01-23
EP1252891A1 (de) 2002-10-30
US6664279B2 (en) 2003-12-16
TWI257864B (en) 2006-07-11
WO2001056569A1 (fr) 2001-08-09
DE60113808T2 (de) 2006-05-18
EP1252891A4 (de) 2003-05-14
EP1252891B1 (de) 2005-10-05

Similar Documents

Publication Publication Date Title
ID22667A (id) Penghambat aktivitas cetp
NO20020968L (no) Glukopyranosyloksypyrazolderivater, medisinske sammensetninger inneholdende det samme og intermediater forfremstillingen derav
NL300215I1 (nl) Depsipeptide-derivaat, productie daarvan en toepassing daarvan.
NO960380D0 (no) Middel til behandling av neurosykdommer
KR987000261A (ko) 벤즈아미드옥심 유도체, 그의 제법 및 농원예용 살균제 (Benzamidoxime Derivative, Proecss for Production Thereof,and Agrohorticultural Bactericide)
CY1111816T1 (el) Παραγωγο θειαδιαζολινης για την θεραπεια του καρκινου
NO20014925L (no) Farmasöytiske forbindelser
AU7517400A (en) N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
ATE399550T1 (de) Heilmittel und vorbeugende mittel für verdauungserkrankungen die diaminotrifluoromethylpyridinverbindungen enthalten
DE60002558D1 (de) Derivate der Phosphonsäure zur Inhibierung von Carboxypeptidase B
DE69623497T2 (de) 1-methylcarbapenem-derivate
ATE305783T1 (de) Verwendung von diaminotrifluoromethylpyridinderivaten für die prevention und behandlung von lebererkrankungen
DE69828197D1 (de) Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut
ATE283840T1 (de) Chondrogonese promotoren und indolin-2-on derivate
ATE135212T1 (de) Arzneimittel für die verhütung und behandlung von krankheiten der kreislauforgane enthaltend spiro- 3-heteroazolidin-verbindungen
ATE511395T1 (de) Mittel zur behandlung von glomerulopathie
ATE275560T1 (de) Bemzimidazolverbindungen und medikamente die diese enthalten
ATE241985T1 (de) Therapeutisches mittel zur behandlung von nierenerkrankungen
ATE359778T1 (de) Mittel zur behandlung von myelopathie

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties